Many patients with SARS-CoV-2 infection develop neurological signs and symptoms; although,
to date, little evidence exists that primary infection of the brain is a significant contributing …

Background Neurological COVID-19 disease has been reported widely, but published studies
often lack information on neurological outcomes and prognostic risk factors. We aimed to …

Elevated levels of the β-amyloid peptide (Aβ) are thought to contribute to cognitive and
behavioral impairments observed in Alzheimer’s disease (AD). Protein phosphatase 2A (PP2A) …

Background Vaccine induced immune medicated thrombocytopenia or VITT, is a recent and
rare phenomenon of thrombosis with thrombocytopenia, frequently including cerebral …

… Kim, Carla Y. a ; Piamonte, Bernadeth b ; Allen, Rebecca c ; Thakur, Kiran T. a … Yao N,
Liu Y, Xu JW, et al. Detection of a highly divergent type 3 vaccine-derived poliovirus in a …

Paucity of the glucose transporter-1 (Glut1) protein resulting from haploinsufficiency of the
SLC2A1 gene arrests cerebral angiogenesis and disrupts brain function to cause Glut1 …

Objective Emerging variants and sublineages of SARS‐CoV‐2 have differing disease severity,
transmissibility, and immune evasion. The neurological conditions associated with the …

Background and Objectives The global spread of the COVID-19 pandemic accelerated the
vaccine development time line, regulatory approval, and widespread implementation in the …

Community-acquired bacterial meningitis (CABM) morbidity and mortality remains high in
those infected. Rapid diagnosis and treatment is paramount to reducing mortality and …

This systematic review evaluates the evidence for accuracy of automated analyzers that
estimate cerebrospinal fluid (CSF) white blood cell counts (WBC) compared to manual …